Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment (Q34024081)

30 July 2017

title

Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment (English)

1 reference

30 July 2017

Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment (English)

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

1 reference

Claire L Shovlin

1

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20870325

20 July 2024

publication date

25 September 2010

1 reference

full work available at URL

30 July 2017

http://spiral.imperial.ac.uk/bitstream/10044/1/22167/2/Shovlin.%20Blood%20Reviews%202010.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20870325

https://api.elsevier.com/content/article/PII:S0268960X10000299?httpAccept=text/xml

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

https://api.elsevier.com/content/article/PII:S0268960X10000299?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

1 reference

30 July 2017

volume

24

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

203-219

1 reference

Hereditary hemorrhagic telangiectasia

30 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pancreatic involvement in hereditary hemorrhagic telangiectasia: assessment with multidetector helical CT.

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Unusual complications after embolization of a pulmonary arteriovenous malformation

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Liver disease in patients with hereditary hemorrhagic telangiectasia

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations

20 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

An epistaxis severity score for hereditary hemorrhagic telangiectasia

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary hemorrhagic telangiectasia epistaxis

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis

20 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation.

20 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study

20 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells

20 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

[Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]

20 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

20 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia/avastin

20 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.

20 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial

20 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter?

20 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Graded contrast echocardiography in pulmonary arteriovenous malformations.

20 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT.

20 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study

20 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Grading of pulmonary right-to-left shunt with transthoracic contrast echocardiography: does it predict the indication for embolotherapy?

20 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study

20 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Migraines linked to intrapulmonary right-to-left shunt

20 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts.

20 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services.

20 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine.

20 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up

20 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations

20 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients

20 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Embolization of pulmonary arteriovenous malformations with amplatzer vascular plugs: safety and midterm effectiveness.

20 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2-20-year follow-up

20 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Management of pulmonary arteriovenous malformations in pulmonary hypertensive patients: a pressure to embolise?

20 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Prophylaxis against infective endocarditis for dental procedures--summary of the NICE guideline

20 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Post-NICE 2008: Antibiotic prophylaxis prior to dental procedures for patients with pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia

20 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years

20 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations: results in 31 patients

20 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The war in my head: coping with arteriovenous malformation after a brain haemorrhage

20 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Evaluation of previously nonscreened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences.

20 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations

20 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study

20 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

20 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Transjugular intrahepatic portosystemic shunt for variceal hemorrhage due to recurrent of hereditary hemorrhagic telangiectasia in a liver transplant

20 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

20 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution

20 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Acute paraplegia due to spinal arteriovenous fistula in two patients with hereditary hemorrhagic telangiectasia.

20 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Spinal arteriovenous shunts presenting before 2 years of age: analysis of 13 cases

20 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT.

20 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Review of radiation risks from computed tomography: essentials for the pediatric surgeon

20 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Radiation dose to the brain and subsequent risk of developing brain tumors in pediatric patients undergoing interventional neuroradiology procedures

20 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature

20 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia

20 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states

20 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia

20 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms

20 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A Lamellar Unit of Aortic Medial Structure and Function in Mammals

20 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications

20 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pulmonary arteriovenous fistula; review of the literature and report of two cases

20 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.

20 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Early adaptive responses of the vascular wall during venous arterialization in mice

20 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

20 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia

20 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia

20 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

20 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.

20 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Functionally Reversible Hepatic Arteriovenous Fistulas During Pregnancy in Patients With Hereditary Hemorrhagic Telangiectasia

20 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Osler-Weber-Rendu disease and pulmonary arteriovenous fistulas. Deterioration and embolotherapy during pregnancy

20 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary telangiectasia and multiple pulmonary arteriovenous fistulas. Clinical deterioration during pregnancy

20 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Medical complications of pregnancy in hereditary haemorrhagic telangiectasia

20 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia

20 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia

20 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The natural history of epistaxis in hereditary hemorrhagic telangiectasia

20 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Life expectancy in patients with hereditary haemorrhagic telangiectasia

20 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia.

20 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia is caused by the Q490X mutation of the ACVRL1 gene in a large Arab family: support of homozygous lethality

20 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family

20 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Inherited diseases of the vasculature

20 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Glaxo/MRS Young Investigator Medal. Molecular studies on adenosine deaminase deficiency and hereditary haemorrhagic telangiectasia

20 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome.

20 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5

20 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes

20 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7.

20 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Characterization of five novel large deletions causing hereditary haemorrhagic telangiectasia

20 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia

20 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

20 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia

20 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The logic of TGFbeta signaling.

20 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding

20 July 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Extracellular control of TGFbeta signalling in vascular development and disease

20 July 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

20 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Signaling cross-talk between TGF-beta/BMP and other pathways

20 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells

20 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Signaling by members of the TGF-beta family in vascular morphogenesis and disease

20 July 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

20 July 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

20 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

The physiological role of endoglin in the cardiovascular system.

20 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex

20 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

20 July 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

20 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway

20 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

20 July 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis

20 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2

20 July 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A murine model of hereditary hemorrhagic telangiectasia

20 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia

20 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2.

20 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations

20 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

20 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

20 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

20 July 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice

20 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor

20 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis.

20 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

20 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endothelial-mural cell signaling in vascular development and angiogenesis

20 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

20 July 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia

20 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1

20 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH.

20 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Inducible expression of human endoglin during inflammation and wound healing in vivo

20 July 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia

20 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism

20 July 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab

20 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Resolution of hereditary hemorrhagic telangiectasia and anemia with prolonged alpha-interferon therapy for chronic hepatitis C.

20 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia

20 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

20 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid

20 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone

20 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Development of targeted angiogenic medicine.

20 July 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density

20 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

20 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?

20 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

20 July 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Thalidomide-induced limb defects: resolving a 50-year-old puzzle

20 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Taking thalidomide out of rehab

20 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia: a clinical analysis

20 July 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3

20 July 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.

20 July 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.

20 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model

20 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation

20 July 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

SIFT: Predicting amino acid changes that affect protein function

20 July 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Cerebral embolism--first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia

20 July 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment

20 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Stroke following pulmonary arteriovenous fistula embolization in a patient with HHT.

20 July 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Gamma knife surgery and arteriovenous malformations

20 July 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Pediatric arteriovenous malformations: a 15-year experience with an emphasis on residual and recurrent lesions

20 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Management and clinical outcome of posterior fossa arteriovenous malformations: report on a single-centre 15-year experience.

20 July 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia

20 July 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life

20 July 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases

20 July 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia

20 July 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract

20 July 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Histological findings following oestrogen treatment of hereditary haemorrhagic telangiectasia. A controlled double-blind investigation

20 July 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Thrombotic events in patients with cancer receiving antiangiogenesis agents

20 July 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer

20 July 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

Reply to Bianca et al.

225

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Should more patients with acute ischaemic stroke receive thrombolytic treatment?

20 July 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

Antibiotic prophylaxis for patients with hereditary hemorrhagic telangiectasia

20 July 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.BLRE.2010.07.001

20 July 2024

Identifiers

1 reference

30 July 2017

1 reference